A drug manufacturer or labeler that sells prescription drugs in the District through any publicly funded pharmaceutical assistance program shall enter into a rebate agreement with the Department under AccessRx. The rebate agreement shall require the manufacturer or labeler to make rebate payments to the District for deposit in the AccessRx Fund each calendar quarter or according to a schedule established by the Department.
(May 18, 2004, D.C. Law 15-164, § 105, 51 DCR 3688.)
This section is referenced in § 48-831.33.
Structure District of Columbia Code
Chapter 8A - Affordability of Prescription Drugs — AccessRx Program
§ 48–831.01. Findings and declaration of intent
§ 48–831.03. Establishment of AccessRx
§ 48–831.07. Operation of program
§ 48–831.08. Discrepancies in rebate amounts
§ 48–831.09. Action with regard to nonparticipating manufacturers and labelers
§ 48–831.11. Eligibility procedures
§ 48–831.12. Method of prescribing or ordering drugs
§ 48–831.13. Third-party administration
§ 48–831.15. Annual summary report
§ 48–831.16. Agreements with governments of other jurisdictions and other entities